相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Disseminated Mycobacterium avium Complex Myositis in a Patient With Graft-Versus-Host Disease
Kathryn Grace Kompa et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
JAK: Not Just Another Kinase
Ruchi P. Agashe et al.
MOLECULAR CANCER THERAPEUTICS (2022)
Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2022)
Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria
Vanessa Daza-Cajigal et al.
FRONTIERS IN IMMUNOLOGY (2022)
Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review
Naruemit Sayabovorn et al.
BMC INFECTIOUS DISEASES (2021)
Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?
Przemyslaw J. Kotyla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The safety of JAK-1 inhibitors
Benjamin Clarke et al.
RHEUMATOLOGY (2021)
Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review
Kartik Anand et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis
Fiorenza Barraco et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Role of JAK inhibitors and immune cells in transplantation
Nicolas Sailliet et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2019)
Mycobacterium marinum infection in fish and man: epidemiology, pathophysiology and management; a review
Emad Hashish et al.
VETERINARY QUARTERLY (2018)
Ruxolitinib-associated infections: A systematic review and meta-analysis
Federico Lussana et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
The emerging safety profile of JAK inhibitors in rheumatic disease
Kevin L. Winthrop
NATURE REVIEWS RHEUMATOLOGY (2017)
Suppression of Mcl-1 induces apoptosis in mouse peritoneal macrophages infected with Mycobacterium tuberculosis
Fei-yu Wang et al.
MICROBIOLOGY AND IMMUNOLOGY (2016)
Twenty-eight cases of Mycobacterium marinum infection: retrospective case series and literature review
Matthew G. Johnson et al.
INFECTION (2015)
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
Alessandro M. Vannucchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
James D. Clark et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Claire Harrison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)